From the Society of Nuclear Medicine meeting exhibit floor, an audio interview with Karthik Kuppusamy, Ph.D., general manger for Americas nuclear medicine, PET/CT, and cyclotron business at GE Healthcare, who touted the company’s Discovery VCT.
At this year's Society of Nuclear Medicine meeting, cardiac PET is emerging from the long shadow of PET/CT for oncology applications. Rejuvenated by increased Medicare reimbursements for perfusion that began this year, PET is also reaping the benefits of a growing body of research supporting its use.
On the SNM exhibit floor, Karthik Kuppusamy, Ph.D., general manger for Americas nuclear medicine, PET/CT, and cyclotron business at GE Healthcare, touted the company's Discovery VCT. The device combines 64-slice CT and high resolution PET as a one-stop shop for assessment of suspected cardiovascular disease. Discovery VCT delivers analyses of ventricular function, wall motion, and perfusion, as well as coronary CT angiograms and calcium scoring, in less than 30 minutes.
But rest and stress imaging using the Discovery VCT to identify perfusion defects presents special challenges that require the deft use of CT during pharmaceutical stress - and a special algorithm developed by GE.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.